Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-036276
Filing Date
2021-03-15
Accepted
2021-03-15 16:30:02
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm219248d2_424b5.htm 424B5 434136
2 GRAPHIC image_002.jpg GRAPHIC 6290
3 GRAPHIC image_003.jpg GRAPHIC 10978
4 GRAPHIC image_005.jpg GRAPHIC 29230
5 GRAPHIC image_004.jpg GRAPHIC 7060
  Complete submission text file 0001104659-21-036276.txt   509683
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-232122 | Film No.: 21741866
SIC: 2834 Pharmaceutical Preparations